Intellipharmaceutics international inc. (IPCI)
CashFlow / Quarterly
Aug'18May'18Aug'17May'17Feb'14Feb'13
Net loss

-3,954

-2,859

-2,550

-1,805

2,201

-1,340

Items not affecting cash
Depreciation

155

153

138

113

71

93

Stock-based compensation (Note 7)

25

63

32

821

6

202

Deferred share units (Note 8)

0

0

7

8

9

9

Accreted interest on convertible debenture (Note 5)

16

16

48

60

-

-

Accrued interest on related party loan

-

-

-

-

-10

-24

Fair value adjustment of derivative liabilities (Notes 5 & 10)

-

-

-

-

-

-1,232

Unrealized foreign exchange loss (gain)

14

9

-95

-18

65

-248

Change in non-cash operating assets & liabilities
Accounts receivable

-182

326

-137

-86

1,614

8

Investment tax credits

45

44

72

-152

62

99

Inventory

64

-25

-305

89

-

-

Prepaid expenses, sundry and other assets

108

58

-296

26

-20

23

Accounts payable, accrued liabilities and employee costs payable

2,594

-429

282

-216

-360

696

Deferred revenue (Note 3)

-75

-75

-75

-75

-

-

Cash flows used in operating activities

-1,287

-3,545

-1,354

-952

217

-1,428

Repayment of principal on convertible debenture (Note 5)

0

0

0

0

-

-

Repayment of capital lease obligations

0

0

3

5

14

12

Proceeds from issuance of common shares on at-the-market financing (Note 6)

0

0

1,047

871

-

-

Proceeds from issuance of common shares on exercise of warrants (Note 6 and 9)

0

0

-28

-29

-

-

Proceeds from issuance of common shares on option exercise (Note 7)

0

0

0

0

29

-

Proceed from issuance of shares and warrants (Note 6 and 9)

0

5,300

0

0

-

-

Proceeds from convertible debenture (Note 7)

-

-

-

-

-

1,500

Issuance of common shares on at-the-market financing (Note 7)

-

-

-

-

4,944

-

Offering costs

0

618

151

55

429

-

Proceeds from issuance of shares on exercise of warrants (Note 10)

-

-

-

-

162

-

Cash flows provided from financing activities

0

4,681

920

840

4,692

1,487

Investing activity
Purchase of property and equipment (Note 4)

15

45

306

797

65

37

Cash flows used in investing activities

-15

-45

-306

-797

-65

-37

Effect of foreign exchange (gain) loss on cash held in foreign currency

-

-

-

-

-

-3

Decrease in cash

-1,303

1,090

-740

-909

4,844

18

Supplemental cash flow information
Interest paid

12

13

0

52

-

-

Interest paid

-

-

-

-

44

10

Taxes paid

0

0

0

0

0

0